Navigation Links
Rice researchers seek better vaccine procedure
Date:9/8/2009

pically contain protection against what scientists consider the three most likely strains of influenza A and influenza B to hit during flu season. But the flu is a master of disguise and can evolve between the spring, when such decisions are made, and the fall, when shots are administered.

"The virus mutates quite a bit," Deem said. "Normally, when we're doing rational drug design, we're trying to do it against a target protein that is not changing, and we're trying to find something that fits very nicely in the pocket of that protein.

"For the flu, these epitopes change. So rational drug design against one strain of the flu virus would only be useful for that one year, and then the virus would mutate the next year."

Deem wants to cut the amount of time between the analysis of flu strains and the manufacture of vaccines to fight them. He and graduate student Keyao Pan can predict the efficacy of H1N1 vaccines by estimating the antigenic "distance" -- the degree of difference between the epitopes -- for any two strains of virus.

Deem's technique assigns a numerical value to the antigenic distance between two strains. That tells researchers just how effective a virus might be. But it also offers a tipping point: If a value of zero is the perfect H1N1 vaccine, a value above roughly 0.4 indicates a vaccine that offers no protection at all.

That means there's a real incentive to formulating the vaccine as close to flu season as possible. It also means choosing strains of the virus that can be produced in high quantities but which are also as close as possible to the virus strain expected to hit. The current process is time-consuming: The novel H1N1 vaccines are incubating in hens' eggs -- the traditional method -- right now, and the United States expects to have 40 million doses in hand by mid-October, with 20 million doses arriving weekly thereafter, said Deem.

His calculations provide incentive to refine cell-bas
'/>"/>

Contact: David Ruth
druth@rice.edu
713-348-6327
Rice University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Researchers find first evidence of virus in malignant prostate cells
2. Diabetes advance: Researchers find gene that causes resistance to insulin
3. Researchers find 2 more genetic risk factors for Alzheimers disease
4. Researchers restore missing protein in rare genetic brain disorder
5. Mayo Clinic researchers find that protein believed to protect against cancer has a Mr. Hyde side
6. Species diversity helps ASU researchers refine analyses of human gene mutations
7. UT Southwestern researchers examine mechanisms that help cancer cells proliferate
8. Marine biomedicine researchers decode structure of promising sea compound
9. Researchers report gene associated with language, speech and reading disorders
10. Bats use love songs during mating, researchers say
11. Idaho researchers win grant to explore DNA frontier
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2015)... March 23, 2015  In the 2014 fiscal year, ... conviction losses. This figure accounts for a fraction of ... The Nilson Report, exceeds $11 billion globally. The polygraph ... a crime has occurred. Investor Mark Saint Juste ... Joe Paolella partnered to administer the test ...
(Date:3/20/2015)... Mar. 19, 2015 Research and Markets ( ... Biometrics - Global Strategic Business Report" report to their ... Iris Biometrics in US$ Thousands. The report provides separate comprehensive ... Japan , Europe , ... and Latin America . Annual ...
(Date:3/17/2015)... NEW YORK , March 17, 2015 /PRNewswire/ ... , the largest exhibition for service robots ever ... . RoboUniverse takes place on May 11-13, 2015 ... Sponsors and exhibitors for the event include: Acorn ... Motion Control; EZ-Robot; Infranor; Kinova Robotics; Littler; NewBotic ...
Breaking Biology News(10 mins):Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2
... A single, oral dose of vitamin A, given to infants shortly ... death by 15 percent, according to a study conducted by researchers ... is published in the July 2008 edition of the journal ... supplementation can reduce mortality in children over 6 months of age. ...
... number of tumor cells circulating in the bloodstream of ... well they are responding to treatment, new results show. ... the European Society for Medical Oncology, researchers showed that ... the outcome after chemotherapy in this hard to treat ...
... would seem a healthier place for toads than a ditch ... scientists have found the opposite is true. In a study ... chemicals pose a threat to amphibians, UF zoologists have found ... from reproductive system abnormalities than toads near farms where ...
Cached Biology News:Newborn vitamin A reduces infant mortality 2New study points to agriculture in frog sexual abnormalities 2New study points to agriculture in frog sexual abnormalities 3
(Date:3/25/2015)... , March 25, 2015  S&P Capital IQ ... Factual Stock Report coverage on Abattis Bioceuticals Corp ... CSE: ATT): is a specialty biotechnology company with ... licensing and marketing proprietary ingredients, bio-similar compounds, patented ... North America . The company ...
(Date:3/25/2015)... Accelovance, a therapeutically focused contract research organization ... Research Organization" at the upcoming Vaccine Industry Excellence (ViE) ... This is the eighth consecutive year Accelovance has ... for "Best Contract Research Organization" in 2009, 2010, and ... "We,re excited to be a finalist for ...
(Date:3/25/2015)... An increase of awareness related to ... of food nutrients, regulatory changes and concerns related to ... demand for natural astaxanthin over the past few years. ... their capacities to satisfy the rising demand. , ... astaxanthin (used in nutraceuticals, aqua feed, food and beverages ...
(Date:3/25/2015)... Francisco, CA (PRWEB) March 25, 2015 ... Support for Novel Mechanism of Action in Neuromuscular ... 25, 2015 – Cytokinetics, Incorporated (Nasdaq: CYTK) announced ... fast skeletal muscle troponin activator tirasemtiv in the ... a Phase IIa “Evidence of Effect” or hypothesis-generating ...
Breaking Biology Technology:S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 5Accelovance Nominated for 2015 Vaccine Industry Excellence (ViE) Awards 2Global Astaxanthin Market to Reach Value of USD 1.1 billion by 2020, Expects Industry Experts in New Report Available at MarketPublishers.com 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 3Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 4Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 5Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 6
... Aug. 20 Inc. magazine announced,its 27th annual Inc. ... Federal Information Technology (IT) services provider,MicroTech, ranks No. 285 ... The 2008 Inc. 500 list measures revenue growth from ... privately held, independent -,no subsidiaries or divisions of other ...
... MINNEAPOLIS, Aug. 20 Medication Management Systems,(MMS) ... North Dakota Pharmacy,Service Corporation -- the result ... therapy management (MTM) health benefit for North,Dakota ... diabetes. The MMS,Assurance Pharmaceutical Care System(TM) will ...
... Six Months Profit Resulting From Enhanced ... Operations and New Agreements, ... ISCR), a leading distributor of at-home testing diagnostics,for the chronically ... e-health and EMR applications, reported,financial results for the second quarter ...
Cached Biology Technology:MicroTech Ranks No. 285 on Inc. Magazine's 2008 List of the 500 Fastest Growing Private Companies in America 2North Dakota Pharmacists and Medication Management Systems Partner to Deliver Quality MTM Services to Patients With Diabetes 2InstaCare Corp. Continues Turnaround & Reports 291% Revenues Increase in 2Q 2008 2InstaCare Corp. Continues Turnaround & Reports 291% Revenues Increase in 2Q 2008 3InstaCare Corp. Continues Turnaround & Reports 291% Revenues Increase in 2Q 2008 4InstaCare Corp. Continues Turnaround & Reports 291% Revenues Increase in 2Q 2008 5InstaCare Corp. Continues Turnaround & Reports 291% Revenues Increase in 2Q 2008 6
... This benchtop ductless exhaust hood ventilates ... safe indoor release of exhaust. Bonded ... Over 28" of vertical clearance (with ... Includes polypropylene spill tray; options include ...
... These versatile enclosures are ... nitrogen or other process ... low-humidity environment. HEPA filtration, ... ionization modules also available, ...
... For the professional, student, or faculty researcher, the ... accelerate your research and improve the quality of ... is the edge that researchers using LI-COR DNA ... years. The 4300 System is a third generation ...
... isolation chamber provides a safe, clean ... pharmaceuticals, in accord with USP-797 requirements. ... (ISO 5) cleanliness conditions in the ... rod and tilt-up front panel for ...
Biology Products: